Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J gets Closure

This article was originally published in The Tan Sheet

Executive Summary

Manufacturer of Band-Aid Liquid Bandage and Dermabond topical adhesive is being acquired by Johnson & Johnson in a cash-for-stock exchange worth roughly $370 mil., the firms announce March 4. Closure will operate as a stand-alone entity reporting through J&J division Ethicon. Liquid Band-Aid sales grew roughly 20% over the prior-year period due to the domestic launch of the Skin Crack Gel line extension. However, sales were negatively impacted by private-label competition. J&J will incur a one-time, after-tax charge of $68 mil.; Closure shareholders will receive $27 for each outstanding share. The addition to the device unit closely follows J&J's purchase of Guidant in December...

You may also be interested in...



J&J Closure acquisition

Johnson & Johnson has completed its acquisition of Closure Medical, the firm announces June 3. The Band-Aid Liquid Bandage and Dermabond topical adhesive maker is being purchased for $370 mil., J&J said when announcing the merger in March (1"The Tan Sheet" March 7, 2005, In Brief)...

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097934

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel